1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur. J. Cancer,2013
2. Castration-resistant prostate cancer: targeted therapies;Leo;Chemotherapy,2011
3. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging;Gleason;J. Urol.,1974
4. Howlader N.N.A., Krapcho M., Garshell J., Neyman N., Altekruse S.F., Kosary C.L., Yu M., Ruhl J., Tatalovich Z., Cho H., Mariotto A., Lewis D.R., Chen H.S., Feuer E.J., Cronin K.A. (eds). SEER Cancer Statistics Review, 1975-2010. http://seer.cancer.gov/scr/1975-2010/. National Cancer Institute. Bethesda, MD; November 2012
5. Screening for prostate cancer: an update;Shariat;Can J. Urol,2008